CardiaTec Bioscience Company
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery
Funding Status:
Pre-Seed
Total Funding:
1400000.0
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Last Funding Date:
2021-01-01
Investors Number:
5.0
Last Funding Type:
Pre-Seed
Industry:
Early Drug Development